{"title":"个性化青光眼药物组合可降低眼压,并可能提高依从性和可负担性","authors":"D. Laroche","doi":"10.24966/OCR-8887/100085","DOIUrl":null,"url":null,"abstract":"We report results from four glaucoma patients on multiple topical medications who refused or failed interventional surgery and opted for in-office medication compounding (n=4). Topical medications with preservatives were compounded into one 10ml-bottle under sterile conditions. Patients used one drop of the compounded solution twice daily. Patients demonstrated significantly reduced IOP and self-reported better compliance after 3 months of use","PeriodicalId":91268,"journal":{"name":"HSOA journal of ophthalmology & clinical research","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-07-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Personalized Glaucoma Medication Compounding Reduces Intraocular Pressure and May Increase Adherence and Affordability\",\"authors\":\"D. Laroche\",\"doi\":\"10.24966/OCR-8887/100085\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"We report results from four glaucoma patients on multiple topical medications who refused or failed interventional surgery and opted for in-office medication compounding (n=4). Topical medications with preservatives were compounded into one 10ml-bottle under sterile conditions. Patients used one drop of the compounded solution twice daily. Patients demonstrated significantly reduced IOP and self-reported better compliance after 3 months of use\",\"PeriodicalId\":91268,\"journal\":{\"name\":\"HSOA journal of ophthalmology & clinical research\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-07-16\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"HSOA journal of ophthalmology & clinical research\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.24966/OCR-8887/100085\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"HSOA journal of ophthalmology & clinical research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.24966/OCR-8887/100085","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Personalized Glaucoma Medication Compounding Reduces Intraocular Pressure and May Increase Adherence and Affordability
We report results from four glaucoma patients on multiple topical medications who refused or failed interventional surgery and opted for in-office medication compounding (n=4). Topical medications with preservatives were compounded into one 10ml-bottle under sterile conditions. Patients used one drop of the compounded solution twice daily. Patients demonstrated significantly reduced IOP and self-reported better compliance after 3 months of use